TYPTF (Entropy Neurodynamics) Buyback Yield %: -16.07 (As of Jun. 29, 2026)


What is Entropy Neurodynamics Buyback Yield %?

Entropy Neurodynamics TYPTF -45.63% Buyback Yield % is -16.07 as of Jun. 29, 2026. The stock has 5 warning signs investors should review. Among 742 Biotechnology companies, Entropy Neurodynamics ranks worse than 61.73% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Entropy Neurodynamics's current buyback yield was -16.07%.

Entropy Neurodynamics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Entropy Neurodynamics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entropy Neurodynamics Buyback Yield % Chart

Entropy Neurodynamics Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun25
Buyback Yield %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -23.02

Entropy Neurodynamics Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.72 0.00 -5.26 -12.96 -15.80

TYPTF vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Entropy Neurodynamics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entropy Neurodynamics Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entropy Neurodynamics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Entropy Neurodynamics's Buyback Yield % falls into.


Entropy Neurodynamics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Entropy Neurodynamics's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.263 + 3.906) / 15.828142
=-23.02%

Entropy Neurodynamics's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-0.412 + 5.947) / 32.512102
=-17.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -16.07 mean?
Entropy Neurodynamics (TYPTF) has a Buyback Yield % of -16.07 as of Jun. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Entropy Neurodynamics and its competitors. According to the industry distribution chart, Entropy Neurodynamics ranks #458 out of 742 companies in the Biotechnology industry, placing it in the top 61.7%.
Is Entropy Neurodynamics' Buyback Yield % too high?
Entropy Neurodynamics' current Buyback Yield % is -16.07. Based on the distribution chart, Entropy Neurodynamics ranks #458 out of 742 companies in the Biotechnology industry, which is below the industry midpoint.
How does Entropy Neurodynamics' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Entropy Neurodynamics ranks #458 out of 742 companies for Buyback Yield %. This places Entropy Neurodynamics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Entropy Neurodynamics and its competitors. Entropy Neurodynamics's current Buyback Yield % is -16.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entropy Neurodynamics stock overvalued right now?
Based on GuruFocus' analysis, Entropy Neurodynamics (TYPTF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 12% above its estimated fair value. The current Buyback Yield % is -16.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Entropy Neurodynamics (TYPTF), the current Buyback Yield % is -16.07 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entropy Neurodynamics Business Description

Other Exchanges ENP:Australia
Address 117 Camberwell Road,, Hawthorn East, Suite 1.01, Camberwell, Melbourne, VIC, AUS, 3123
Entropy Neurodynamics Ltd is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. The company's lead program is TRP-8803. TRP-8803 is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe.